Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121858 · ClinicalTrials.gov registry record · NA
Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 706
- Enrollment target
NCT04121858 is a NA study that has completed, run by Indiana University. The registered enrollment target is 706 participants.
The verdict
NCT04121858, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 706 participants
- Enrollment target
Study Summary
This study is an RCT to evaluate the effectiveness of Brain Safe on reducing anticholinergic exposure. Over 42 months, the trial will enroll 700 community-dwelling older adults who were prescribed one or more strong anticholinergics. Participants will be randomized to use the Brain Safe app or an attention control medication list app for 12 months, with monthly usage reminders.
Interventions
- OTHER Brain Safe App
- OTHER Attention Control App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 706 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2025-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04121858
The ClinicalTrials.gov registry entry for NCT04121858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 706 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brain Safe App is the first listed.
NCT04121858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04121858 about?
NCT04121858 is a clinical study titled "Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease". This study is an RCT to evaluate the effectiveness of Brain Safe on reducing anticholinergic exposure. Over 42 months, the trial will enroll 700 community-dwelling older adults who were prescribed one or more strong anticholinergics. Participants will be randomized to use the Brain Safe app or an at...
What is the current status of trial NCT04121858?
This trial is currently completed. It is a NA study. The enrollment target is 706 participants. The study started on 2019-10-16. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT04121858?
The interventions under investigation include: Brain Safe App (OTHER), Attention Control App (OTHER).
Who is sponsoring clinical trial NCT04121858?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.